Tango stock plunges 28% amid pipeline updates, Q3 earnings report
Tango Therapeutics (NASDAQ:TNGX) stock plunged 28% in morning trading Wednesday after the company announced updates on ...
ETF Daily News12d
B. Riley Lowers Tango Therapeutics (NASDAQ:TNGX) Price Target to $8.00
The business has a 50 day moving average price of $7.24 and a 200 day moving average price of $8.26. Tango Therapeutics has a ...
FierceBiotech19d
Tango has last dance with PRMT5 inhibitor, pirouettes into embrace with 2 sibling molecules
Tango Therapeutics has shuffled TNG908 off the dance floor, halting enrollment in a study of the cancer drug candidate to focus its resources on two other molecules that hit the same target.